| Title | Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Powell, Suzanne E., Susan Hariri, Martin Steinau, Heidi M. Bauer, Nancy M. Bennett, Karen C. Bloch, Linda M. Niccolai, Sean Schafer, Elizabeth R. Unger, and Lauri E. Markowitz |
| Journal | Vaccine |
| Volume | 31 |
| Issue | 1 |
| Pagination | 109-13 |
| Date Published | 2012 Dec 17 |
| ISSN | 1873-2518 |
| Keywords | Adolescent, Adult, Cervical Intraepithelial Neoplasia, Female, Human papillomavirus 16, Human papillomavirus 18, Humans, Papillomaviridae, Papillomavirus Vaccines, Uterine Cervical Diseases, Young Adult |
| Abstract | Vaccination against human papillomavirus (HPV) types 16 and 18 is recommended for girls aged 11 or 12 years with catch-up vaccination through age 26 in the U.S. Cervical intraepithelial neoplasia (CIN) grade 2 or 3 and adenocarcinoma in situ (CIN2+) are used to monitor HPV vaccine impact on cervical disease. This report describes vaccination status in women diagnosed with CIN2+ and examines HPV vaccine impact on HPV 16/18-related CIN2+. |
| DOI | 10.1002/cncr.28038 |
| Alternate Journal | Vaccine |
